enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. The #1 Commonly Missed Early Sign of Lung Cancer ... - AOL

   www.aol.com/1-commonly-missed-early-sign...

   But the bottom line is this: "If lung cancer can be diagnosed at an early stage, the patient will have more treatment options and a better chance of remission," says Dr. Xiuning Le, MD, PhD, a V ...

3. Treatment of lung cancer - Wikipedia

   en.wikipedia.org/wiki/Treatment_of_lung_cancer

   Prior to the early part of the 20th century lung cancer was considered a very rare disease, and all malignant lung tumors were treated identically. [66] Radical surgical resection (i.e. lobectomy [ 67 ] [ 68 ] or pneumonectomy ) [ 69 ] was the only effective intervention available for lung cancer prior to the 1940s, when the era of modern ...

4. Lambert–Eaton myasthenic syndrome - Wikipedia

   en.wikipedia.org/wiki/Lambert–Eaton_myasthenic...

   LEMS is often associated with lung cancer (50–70%), specifically small-cell carcinoma, [4] making LEMS a paraneoplastic syndrome. [5] Of the people with small-cell lung cancer, 1–3% have LEMS. [3] In most of these cases, LEMS is the first symptom of the lung cancer, and it is otherwise asymptomatic. [3]

5. Woman, 55, who never smoked reveals the 1 symptom that ... - AOL

   www.aol.com/news/woman-55-never-smoked-reveals...

   55-year-old Devonne Swift never smoked. After developing a persistent cough, she received a lifesaving early lung cancer diagnosis – all thanks to a new technology, robotic bronchoscopy.

6. Lung cancer - Wikipedia

   en.wikipedia.org/wiki/Lung_cancer

   Integrating palliative care (medical care focused on improving symptoms and lessening discomfort) into lung cancer treatment from the time of diagnosis improves the survival time and quality of life of those with lung cancer. [50] Particularly common symptoms of lung cancer are shortness of breath and pain.

7. Merus Scores Its First FDA Approval For Lung Cancer Drug - AOL

   www.aol.com/merus-scores-first-fda-approval...

   On Wednesday, the FDA approved Merus N.V.’s (NASDAQ:MRUS) Bizengri (zenocutuzumab-zbco) as the first and only treatment indicated for adults with pancreatic adenocarcinoma or non–small cell ...